Abstract
Objective
To explore the role of endothelin-1 (ET-1) and leptin in intrauterine growth restriction (IUGR) among preeclamptic and non-pre-eclamptic women.
Methods
Forty three patients with a pregnancy complicated by IUGR, 23 cases with severe pre-eclampsia and 20 cases of non-pre-eclamptic were enrolled. Control group comprised 15 cases with uncomplicated pregnancy. Blood samples from umbilical artery and maternal venous blood were collected at the time of delivery for analysis of ET-1 and leptin levels. Mode of delivery, birth weight and Apgar score were also recorded.
Results
The mean maternal and fetal ET-1 level was significantly higher in pregnancies complicated by IUGR than in control group. The mean maternal leptin level was significantly higher in pre-eclamptic patients when compared to non-preeclamptic and control groups. Mean fetal leptin level was significantly lower in patients compared to control; however, when fetal leptin corrected to fetal weight, it was insignificantly different in the both groups. E-mail: m. alhaggar@yahoo.co.uk.
Conclusion
Maternal plasma ET-1 and leptin correlate with the degree of fetal growth restriction originating from deterioration of placental function. Maternal plasma leptin and ET-1 levels may reflect deterioration in fetal growth.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Change history
01 March 2024
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1007/s12098-024-05093-2
References
McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340: 1234–1238.
Lackman F, Capewell V, Richardson B, daSilva O, Gagnon R. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. Am J Obstet Gynecol 2001; 184: 946–953.
Neerhof MG, Silver RK, Caplan MS, Thaete LG. Endothelin-1-induced placental and fetal growth restriction in the rat. J Matern Fetal Med 1997; 6: 125–128.
Thaete LG, Neerhof MG, Silver RK. Differential effects of Endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats. J Soc Gynecol Investig 2001; 8: 18–23.
Yura S, Itoh H, Sagawa N et al. Role of premature leptin surge in obesity resulting from intrauterine undernutrition. Cell Metab 2005; 1: 371–378.
Freidman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763–770.
Laivuori H, Gallaher MJ, Collura L et al. Relationship between maternal plasmas leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia. Mol Hum Reprod 2006; 2: 551–556.
Cunningham SG, Leveno TJ, Bloom SL, Hautch JC, Jilstrapl, Wanstron CD. Hypertensive disorders in pregnancy. In Williams Obstetrics, 21st ed. McGraw-Hill, Medical Publishing Division; New York, 2005; 761–808.
Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308: 1592–1594.
Di Iorio R, Marinoni E, Anceschi MM, Emiliani S, Letizia C, Cosmi EV. Amniotic fluid Endothelin-1 levels are increased in pregnancy-induced hypertension and intrauterine growth retardation. Am J Reprod Immunol 1996; 36: 260–263.
Hitschold TP. Doppler flow velocity waveforms of the umbilical arteries correlate with intravillous blood volume. Am J Obstet Gynecol 1998; 179: 540–543.
Erdem A, Erdem M, Himmetoglu O et al. Maternal and fetal plasma Endothelin levels in intrauterine growth restriction: relation to umbilical artery Doppler flow velocimetry. J Perinatal Med 2003; 31: 52–59.
Arslan M, Yazici G, Erdem A, Erdem M, Arslan EO, Himmetoglu O. Endothelin-1 and leptin in the pathophysiology of intrauterine growth restriction. Int J Gyn and Ob 2004; 84: 120–126.
Houseknetch KL, Mantzoros CS, Kuliawat R, Hadro E, Flier JS, Kahn BB. Evidence of leptin binding in serum of rodents and humans: modulation with obesity. Diabetes 1996; 45: 1638–1643.
Pighetti M, Tommaselli GA, D’Elia A et al. Maternal serum and umbilical cord blood leptin concentrations with fetal growth restriction. Obstet Gynecol 2003; 102: 535–543.
Mise H, Yura S, Itoh H et al. The relationship between maternal plasma leptin levels and fetal growth restriction. Endocr J 2007; 54: 945–951.
Lepercq J, Guerre-Millo M, Andre J, Cauzac M, Hauguel-de Mouzon S. Leptin: a potential marker of placental insufficiency. Obstet Gynecol 2003; 55: 151–155.
Smith JT, Waddell BJ. Leptin distribution and metabolism in the pregnant rat: transplacental leptin passage increases in late gestation but is reduced by excess glucocorticoids. Endocrinology 2003; 144: 3024–3030.
Lea RG, Howe D, Hannah LT, Bonneau O, Hunter L, Hoggard N. Placental leptin in normal, diabetic and fetal growth-retarded pregnancies. Mol Hum Reprod 2000; 6:763–769.
Quenberger P, Exner M, Sunder-Plassmann R et al. Leptin induces Endothelin-1 in endothelial cells in vitro. Circ Res 2002; 90: 711–718.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1007/s12098-024-05093-2"
About this article
Cite this article
Nezar, M.AS., El-Baky, A.M.A., Soliman, O.AS. et al. RETRACTED ARTICLE: Endothelin-1 and leptin as markers of intrauterine growth restriction. Indian J Pediatr 76, 485–488 (2009). https://doi.org/10.1007/s12098-009-0079-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-009-0079-0